Molecule Details
| InChIKey | UXZFQZANDVDGMM-UHFFFAOYSA-N |
|---|---|
| Compound Name | 5,7-Diiodo-8-hydroxyquinoline |
| Canonical SMILES | Oc1c(I)cc(I)c2cccnc12 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.38 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB09115 |
|---|---|
| Drug Name | Diiodohydroxyquinoline |
| CAS Number | 83-73-8 |
| Groups | approved |
| ATC Codes | G01AC01 |
| Description | Diiodohydroxyquinoline, also known as uidoquinol and iodoquinol, is a quinoline derivative that can be used in the treatment of amoebiasis. The exact mechanism of action is unknown. Iodoquinol is not currently available in any FDA-approved products. |
Categories: Amebicides Anti-Infective Agents Antiparasitic Agents Antiprotozoals Genito Urinary System and Sex Hormones Gynecological Antiinfectives and Antiseptics Heterocyclic Compounds, Fused-Ring Hydroxyquinolines Quinoline Derivatives Quinolines
Cross-references: BindingDB: 66035 ChEBI: 5950 CHEMBL86754 ChemSpider: 3597 Drugs Product Database (DPD): 6848 C07636 D00581 PubChem:3728 PubChem:310265032 RxCUI: 3435 Wikipedia: Diiodohydroxyquinoline ZINC: ZINC000003830942
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P28482 | MAPK1 | Homo sapiens | Human | PF00069 | 6.5 | IC50 | ChEMBL |
| Q16539 | MAPK14 | Homo sapiens | Human | PF00069 | 6.4 | IC50 | ChEMBL |
| P0DMS8 | ADORA3 | Homo sapiens | Human | PF00001 | 6.2 | IC50 | ChEMBL |
| P04626 | ERBB2 | Homo sapiens | Human | PF00757 PF14843 PF07714 PF01030 PF21314 | Clinical | TTD_MultiTarget | TTD_MultiTarget |